Ignite Creation Date:
2024-05-06 @ 3:59 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02423512
Status:
COMPLETED
Last Update Posted:
2017-09-13
First Post:
2015-04-17
Brief Title:
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness
Sponsor:
Organization:
Icahn School of Medicine at Mount Sinai
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Whole blood serum mucosal tissue
Enrollment Count:
50
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 29882 |
Who Masked List: